MedTrace Logo

Safety and Efficacy Study of Nitric Oxide in Patients Going Through Lung Transplantation

NCT00570245 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2016-10-19

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of inhaled nitric oxide in prevention of lung graft dysfunction due to ischemia-reperfusion

Conditions

  • Lung Transplantation

Interventions

DRUG

Nitric oxide

inhalation, 10 ppm, for up to 48 hours

DRUG

Nitric oxide

inhalation; 10ppm; 3 hours (donor) up to 48 hours (recipient)

Sponsors & Collaborators

  • Mallinckrodt

    lead INDUSTRY

Principal Investigators

  • Rosario Vicente, MD · Hospital General La Fe

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00570245 on ClinicalTrials.gov